BSE Live
Apr 17, 16:01Prev. Close
1129.60
Open Price
1122.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 17, 15:56Prev. Close
1128.35
Open Price
1130.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Laurus Labs (in Rs. Cr.) | Mar 15 | |
| 12 mths | ||
| EQUITIES AND LIABILITIES | ||
| SHAREHOLDER'S FUNDS | ||
| Equity Share Capital | 15.51 | |
| Total Share Capital | 82.13 | |
| Reserves and Surplus | 641.93 | |
| Total Reserves and Surplus | 641.93 | |
| Total Shareholders Funds | 724.05 | |
| Minority Interest | 0.00 | |
| NON-CURRENT LIABILITIES | ||
| Long Term Borrowings | 303.68 | |
| Deferred Tax Liabilities [Net] | 11.30 | |
| Other Long Term Liabilities | 44.66 | |
| Long Term Provisions | 5.13 | |
| Total Non-Current Liabilities | 364.76 | |
| CURRENT LIABILITIES | ||
| Short Term Borrowings | 431.64 | |
| Trade Payables | 230.81 | |
| Other Current Liabilities | 133.34 | |
| Short Term Provisions | 9.20 | |
| Total Current Liabilities | 804.99 | |
| Total Capital And Liabilities | 1,893.80 | |
| ASSETS | ||
| NON-CURRENT ASSETS | ||
| Tangible Assets | 794.90 | |
| Intangible Assets | 6.12 | |
| Capital Work-In-Progress | 109.67 | |
| Fixed Assets | 910.68 | |
| Non-Current Investments | 7.45 | |
| Deferred Tax Assets [Net] | 0.00 | |
| Long Term Loans And Advances | 96.45 | |
| Other Non-Current Assets | 13.97 | |
| Total Non-Current Assets | 1,028.55 | |
| CURRENT ASSETS | ||
| Current Investments | 0.00 | |
| Inventories | 475.50 | |
| Trade Receivables | 285.07 | |
| Cash And Cash Equivalents | 58.89 | |
| Short Term Loans And Advances | 31.18 | |
| OtherCurrentAssets | 14.62 | |
| Total Current Assets | 865.25 | |
| Total Assets | 1,893.80 | |
| OTHER ADDITIONAL INFORMATION | ||
| CONTINGENT LIABILITIES, COMMITMENTS | ||
| Contingent Liabilities | 306.95 | |
| BONUS DETAILS | ||
| Bonus Equity Share Capital | 0.00 | |
| NON-CURRENT INVESTMENTS | ||
| Non-Current Investments Quoted Market Value | 0.00 | |
| Non-Current Investments Unquoted Book Value | 7.45 | |
| CURRENT INVESTMENTS | ||
| Current Investments Quoted Market Value | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 |
08.04.2026
02.04.2026
22.03.2026
Sell-on-rise market? SBI Securities sees Nifty under pressure, picks two stocks for the week ahead
20.03.2026
27.01.2026
Laurus Labs Consolidated December 2025 Net Sales at Rs 1,778.29 crore, up 25.67% Y-o-Y
27.01.2026
Laurus Labs Standalone December 2025 Net Sales at Rs 1,509.42 crore, up 19.3% Y-o-Y
28.10.2025
Laurus Labs Consolidated September 2025 Net Sales at Rs 1,653.47 crore, up 35.12% Y-o-Y
27.10.2025
Laurus Labs Standalone September 2025 Net Sales at Rs 1,566.60 crore, up 32.22% Y-o-Y
12.04.2021
Laurus Labs Q4 PAT seen up 366.3% YoY to Rs. 232.2 cr: Sharekhan
18.01.2019
Laurus Labs Q3 PAT may dip 48.3% YoY to Rs. 17.8 cr: Sharekhan
17.10.2018
Laurus Labs Q2 PAT may dip 46.7% YoY to Rs. 30 cr: HDFC Securities
17.10.2018
Laurus Labs Q2 PAT may dip 49.4% YoY to Rs. 24.5 cr: Sharekhan
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth